About this Event
Imperial Collider returns, providing you the opportunity to meet world-leading researchers across Imperial's health and innovation ecosystem. Come along to hear from startup and spinout founders from our community, representatives from funding and investment organisations, and leading industry figures in health, pharma and biosciences.
This year, our keynote speaker is Dr Fiona Marshall, President of Biomedical Research at Novartis, who will bring her extensive experience and cross-cutting expertise to inspire impact-making innovation throughout the community.
Look out for the full speaker lineup and ways to sponsor and partner at the event soon.
What else do I need to know?
- Please complete your registration in full to confirm your job title, company, and dietary and accessibility requirements.
- This is a ticketed event with limited space. We reserve the right to cancel your ticket.
- There will be photography and filming at this event.
- For venue accessibility information, please contact Prashanthini (Prasshy) Jeyarajan: [email protected]
- All guests registering for this event will be expected to adhere to Imperial’s Institutional Events code of conduct.
- Imperial College London – Enterprise Division Privacy Notice
For all other questions, please contact Prashanthini (Prasshy) Jeyarajan: [email protected]
Agenda
🕑: 08:30 AM - 09:20 AM
Registration and morning coffee
🕑: 09:20 AM - 09:30 AM
Opening remarks
Info: Mary Ryan, Vice Provost, Research and Enterprise, Imperial
🕑: 09:30 AM - 10:15 AM
Opening keynote – Accessing innovation to drive the pharma pipeline
Info: Fiona Marshall, President, Biomedical Research, Novartis
🕑: 10:15 AM - 10:45 AM
Flagship Translational Journey I: The Discovery and Translation of GLP Biology
Info: TBA
🕑: 10:45 AM - 11:15 AM
Flagship Translational Journey II: A Rhinovirus Vaccine
Info: Sebastian Johnston, Professor, Respiratory Medicine & Allergy, Imperial
🕑: 11:15 AM - 11:35 AM
Morning break & networking
🕑: 11:35 AM - 12:05 PM
Fleming in practice: tackling grand challenges in antimicrobial resistance
Info: TBA
🕑: 12:05 PM - 12:55 PM
Panel – Biomedical sector landscape and key trends
Info: Fiona Marshall, President, Biomedical Research, Novartis; Ruth McKernan, Operating Partner, SV Health Investors; Richard Mason, Chief Executive Officer, Apollo Therapeutics; Jose-Carlos Gutierrez-Ramos, Senior Vice President and Chief Science Officer, Danaher; Chair: Mike Romanos, Associate Dean for Enterprise, Imperial College London
🕑: 12:55 PM - 01:50 PM
Lunch & networking
🕑: 01:50 PM - 02:35 PM
Keynote – Innovation to enable the pharma industry and precision medicine
Info: Jose-Carlos Gutierrez-Ramos, Senior Vice President and Chief Science Officer, Danaher
🕑: 02:35 PM - 02:55 PM
Imperial’s clinical advantage: patients, cohorts and translational depth
Info: Graham Cooke, Deputy Dean of the Faculty of Medicine, Imperial.
🕑: 02:55 PM - 03:10 PM
Convergence in practice: Digital health, data and the next frontier
Info: Payam Barnaghi, Co-Director, School of Convergence Science (Human and Artificial Intelligence), Imperial College London
🕑: 03:10 PM - 03:55 PM
Panel – Partnering that works: identifying science and building collaboration
Info: Kay Penicud, Vice President and Head of Research Partnerships, Apollo Therapeutics; Arjen Lemmen, VP Corporate Development & Strategy, Argenx; Malcolm Skingle, Former Head of Academic Liaison, GSK; Chair: Prasshy Jeyarajan, Head of Partnerships, Faculty of Medicine, Imperial
🕑: 03:55 PM - 04:50 PM
Translational Science Showcase
Info: TBA
🕑: 04:50 PM - 04:55 PM
Closing reflections - Sustaining momentum beyond the Collider
Info: Graham Cooke, Deputy Dean of Faculty of Medicine Imperial College London
Event Venue & Nearby Stays
The Royal Geographical Society (with IBG), 1 Kensington Gore, London, United Kingdom
GBP 0.00
